Skip to content
About Us
Menu Toggle
Overview
Founder
Executives
Scientific Advisors
Technologies
Menu Toggle
Overview
Multi-arm linkers
Cytotoxic drug bundles
Dual-drug cytotoxic drug bundles
Chelator bundles
CHO-TEM antibody drug conjugates
Antibody radionuclide conjugates (ARCs)
Products
Menu Toggle
Overview
TE-1146
TE-1182
TE-1132
News and Honours
Menu Toggle
Join our presentation at the World ADC Asia 2025 Conference
【Reported by Taiwan Global Bio Monthly】The President, Dr. Tse-Wen Chang was invited as a keynote speaker at Biologics World Taiwan 2025
T-E Pharma Holding to Launch IPO Plan in 2026
T-E Meds and Orient EuroPharma Forge Licensing Agreement for TE-1146
Join our presentation at the World ADC San Diego 2024
Join our presentation at the BIO Asia-Taiwan 2024 Conference
Join our presentation at the World ADC Asia 2024 Conference
Our latest research result is published in Advanced Science
Join Our presentation at The BiG ADC/XDC Conference
Join Our presentation at The 5th ADC Development Summit
Join Our presentation at the prestigious J.P. Morgan Healthcare Conference
FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Join our presentation at the World ADC San Diego 2023!
T-E Meds has received an invitation to present the latest ADC technology platform at the World ADC San Diago conference
T-E Meds and CHO Pharma offer complementary technologies to form a robust ADC development platform
Our latest research result is published in J. Med. Chem.
Immunwork links future to T-E Meds, promoting ADC, ARC platforms development
BIO 2023 International Convention in Boston
Recruitment Notice
Language
Menu Toggle
English
繁體中文
About Us
Menu Toggle
Overview
Founder
Executives
Scientific Advisors
Technologies
Menu Toggle
Overview
Multi-arm linkers
Cytotoxic drug bundles
Dual-drug cytotoxic drug bundles
Chelator bundles
CHO-TEM antibody drug conjugates
Antibody radionuclide conjugates (ARCs)
Products
Menu Toggle
Overview
TE-1146
TE-1182
TE-1132
News and Honours
Menu Toggle
Join our presentation at the World ADC Asia 2025 Conference
【Reported by Taiwan Global Bio Monthly】The President, Dr. Tse-Wen Chang was invited as a keynote speaker at Biologics World Taiwan 2025
T-E Pharma Holding to Launch IPO Plan in 2026
T-E Meds and Orient EuroPharma Forge Licensing Agreement for TE-1146
Join our presentation at the World ADC San Diego 2024
Join our presentation at the BIO Asia-Taiwan 2024 Conference
Join our presentation at the World ADC Asia 2024 Conference
Our latest research result is published in Advanced Science
Join Our presentation at The BiG ADC/XDC Conference
Join Our presentation at The 5th ADC Development Summit
Join Our presentation at the prestigious J.P. Morgan Healthcare Conference
FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Join our presentation at the World ADC San Diego 2023!
T-E Meds has received an invitation to present the latest ADC technology platform at the World ADC San Diago conference
T-E Meds and CHO Pharma offer complementary technologies to form a robust ADC development platform
Our latest research result is published in J. Med. Chem.
Immunwork links future to T-E Meds, promoting ADC, ARC platforms development
BIO 2023 International Convention in Boston
Recruitment Notice
Language
Menu Toggle
English
繁體中文
Recruitment Notices
Scroll to Top
